VIR BIOTECHNOLOGY INC's ticker is VIR and the CUSIP is 92764N102. A total of 209 filers reported holding VIR BIOTECHNOLOGY INC in Q3 2023. The put-call ratio across all filers is 0.58 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $431,498 | -60.5% | 46,051 | +3.4% | 0.00% | -57.1% |
| Q2 2023 | $1,092,934 | +18.0% | 44,555 | +11.9% | 0.01% | +16.7% |
| Q1 2023 | $926,146 | -7.7% | 39,800 | +0.4% | 0.01% | -14.3% |
| Q4 2022 | $1,003,516 | +30.3% | 39,649 | -0.7% | 0.01% | +16.7% |
| Q3 2022 | $770,000 | -23.3% | 39,947 | +1.4% | 0.01% | -14.3% |
| Q2 2022 | $1,004,000 | +30.7% | 39,408 | +32.0% | 0.01% | +75.0% |
| Q1 2022 | $768,000 | -42.6% | 29,846 | -6.6% | 0.00% | -42.9% |
| Q4 2021 | $1,338,000 | -6.6% | 31,946 | -2.9% | 0.01% | -12.5% |
| Q3 2021 | $1,432,000 | -10.1% | 32,903 | -2.3% | 0.01% | +60.0% |
| Q2 2021 | $1,593,000 | -0.5% | 33,684 | +7.9% | 0.01% | -16.7% |
| Q1 2021 | $1,601,000 | +92.0% | 31,227 | +0.3% | 0.01% | +100.0% |
| Q4 2020 | $834,000 | -24.2% | 31,145 | -2.8% | 0.00% | -40.0% |
| Q3 2020 | $1,100,000 | -5.2% | 32,039 | +13.1% | 0.01% | -16.7% |
| Q2 2020 | $1,160,000 | +694.5% | 28,318 | +564.0% | 0.01% | +500.0% |
| Q1 2020 | $146,000 | +156.1% | 4,265 | -5.5% | 0.00% | – |
| Q4 2019 | $57,000 | – | 4,512 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SB INVESTMENT ADVISERS (UK) LTD | 22,616,666 | $284,405,000 | 3.12% |
| INDUS CAPITAL PARTNERS, LLC | 681,936 | $8,575,000 | 1.68% |
| Alphabet Inc. | 1,666,666 | $20,958,000 | 1.27% |
| Temasek Holdings (Private) Ltd | 5,499,999 | $69,162,000 | 0.45% |
| Board of Trustees of The Leland Stanford Junior University | 38,905 | $490,000 | 0.06% |
| Baillie Gifford | 500,000 | $6,287,000 | 0.01% |
| Marshall Wace North America L.P. | 74,898 | $941,000 | 0.01% |
| Capital International Investors | 983,300 | $12,365,000 | 0.00% |
| Blackstone Inc. | 35,000 | $440,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 1,908 | $24,000 | 0.00% |